oxonic acid has been researched along with Ache in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients were eligible for the study if they had histologically documented gastric adenocarcinoma previously treated with paclitaxel and cisplatin, age > or = 18 years, Eastern Clinical Oncology Group performance status < or =2, adequate organ function, and no evidence of gastrointestinal obstruction or passage disturbance." | 5.14 | Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer. ( Bae, WK; Cho, SH; Chung, IJ; Hwang, JE; Lee, SJ; Shim, HJ; Yoon, JY, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, E | 1 |
| Kinoshita, K | 1 |
| Yoshida, Y | 1 |
| Iizaka, M | 1 |
| Inoue, K | 1 |
| Uto, N | 1 |
| Lee, SJ | 1 |
| Cho, SH | 1 |
| Yoon, JY | 1 |
| Hwang, JE | 1 |
| Bae, WK | 1 |
| Shim, HJ | 1 |
| Chung, IJ | 1 |
1 trial available for oxonic acid and Ache
| Article | Year |
|---|---|
Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic | 2009 |
1 other study available for oxonic acid and Ache
| Article | Year |
|---|---|
[Successful control of pancreatic cancer pain using S-1 chemotherapy--a case report].
Topics: Analgesics, Opioid; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Endoscopy, Ga | 2008 |